C4 Therapeutics (CCCC) Q4 2025 Earnings

6NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.49
-0.45
-0.41
-0.37

Details

Expected EPS
-0.405714
Actual EPS
-0.44
Surprise EPS
-0.03
Surprise Percent
+8.45%

Description

C4 Therapeutics (CCCC) has reported earnings of -0.44 per share for Q4 2025.

0 Comments

Share your thoughts